novel
mannosebind
lectin
design
cml
isol
clemati
montana
buchham
stem
ranunculacea
use
ion
exchang
gel
filtrat
chromatographi
deaesepharos
sephacryl
purifi
c
montana
lectin
homodim
da
subunit
determin
gel
filtrat
ms
hemagglutin
activ
cml
inhibit
branch
oligomannosid
ntermin
acid
sequenc
cml
dnvkysgqvkntgsa
report
lectin
also
peptid
mass
fingerprint
assay
confirm
match
result
similar
plant
lectin
cml
indic
cml
may
novel
plant
lectin
cml
show
mark
antivir
activ
variou
virus
cell
cultur
subsequ
cml
also
found
exhibit
remark
inhibitori
effect
hela
cell
furthermor
cml
special
induc
cell
apoptosi
dosedepend
manner
evidenc
mtt
fluoresc
microscopi
ldh
activitybas
cytotox
assay
dna
ladder
moreov
due
caspas
inhibitor
western
blot
analys
caspas
also
found
play
import
role
potenti
apoptot
mechan
cml
carbohydratebind
site
fulli
inhibit
sugar
cytotox
abruptli
decreas
apoptot
phenomenon
cell
observ
suggest
signific
correl
mannosebindingspecif
activ
antineoplast
mechan
crown
lectin
carbohydratebind
protein
bind
carbohydr
revers
possess
abil
agglutin
cell
precipit
polysaccharid
glycoconjug
wide
distribut
anim
plant
microorgan
attract
great
interest
due
variou
biolog
activ
cell
agglutin
antitumor
immunomodulatori
antifung
antivir
antiinsect
activ
report
great
number
lectin
eg
mistleto
lectin
concanavalin
cona
polygonatum
cyrtonema
lectin
induc
apoptosi
tumor
cell
therefor
plant
lectin
alreadi
adopt
altern
tumor
therapi
europ
sever
year
clemati
genu
consist
speci
climb
shrub
mainli
distribut
subtrop
countri
acrid
poison
plant
clemati
genu
use
tradit
medicin
india
china
leav
clemati
montana
util
treatment
skin
diseas
india
china
clemati
armandii
c
montana
call
mu
tong
also
use
tradit
chines
medicin
treatment
ailment
reduc
fever
induc
urin
stimul
menstrual
discharg
promot
lactat
nevertheless
two
speci
contain
differ
compon
c
montana
triterpenoid
glycosid
major
compon
c
armandii
mainli
contain
flavonoid
howev
investig
report
bioactiv
protein
clemati
genu
besid
cyclic
compound
eg
alkaloid
triterpenoid
flavanon
report
previous
nacetylgalactosaminespecif
lectin
purifi
winter
aconit
eranthi
hyemali
repres
plant
famili
ranunculacea
lectin
consid
first
lectin
isol
famili
ranunculacea
studi
purifi
character
novel
mannosebind
lectin
stem
c
montana
belong
plant
famili
ranunculacea
well
subsequ
c
montana
lectin
cml
found
bear
remark
antivir
activ
vitro
varieti
dna
rna
virus
cell
cultur
furthermor
show
lectin
possess
potent
antitumor
activ
direct
cytotox
four
typic
cancer
cell
found
apoptosi
cell
importantli
explor
caspas
play
crucial
role
potenti
mechan
apoptosi
moreov
sugarinhibitori
analysi
signific
correl
discov
sugarbind
specif
cml
apoptosisinduc
mechan
mention
result
would
provid
insight
clue
understand
key
role
lectin
cancer
investig
airdri
slice
akebia
clemati
stem
purchas
local
tradit
chines
medicin
market
chengdu
china
identifi
c
montana
buchham
ranunculacea
hela
cell
provid
medic
scienc
center
west
china
sichuan
univers
deaesepharos
sephacryl
standard
molecular
weight
marker
procur
pharmacia
pharmacia
uppsala
sweden
dulbecco
modifi
eagl
medium
dmem
rpmi
medium
suppli
gibco
grand
island
ny
saccharid
glycoprotein
acridin
orang
ao
zdevdfmk
zietdfmk
zvadfmk
bromid
mtt
product
sigma
chemic
st
loui
mo
usa
abo
blood
group
erythrocyt
obtain
healthi
donor
fresh
rabbit
chook
blood
cell
obtain
local
market
dri
stem
slice
powder
extract
overnight
mm
naachac
buffer
ph
centrifug
g
min
result
supernat
obtain
appli
column
deaesepharos
cm
cm
column
equilibr
mm
naachac
buffer
ph
activ
fraction
concentr
purifi
sephacryl
column
cm
cm
preequilibr
mm
pb
ph
protein
concentr
determin
accord
method
bradford
use
bovin
serum
albumin
bsa
standard
hemagglutin
activ
cml
determin
microtit
u
plate
method
serial
doubl
dilut
method
use
suspens
rabbit
erythrocyt
lectin
ml
serial
dilut
nacl
equal
volum
erythrocyt
suspens
ad
microtit
plate
mixtur
incub
h
room
temperatur
plate
read
hemagglutin
titer
defin
reciproc
highest
dilut
exhibit
hemagglutin
defin
one
hemagglutin
unit
specif
hemagglutin
activ
defin
unitmg
protein
specif
lectin
human
group
b
chook
erythrocyt
perform
similar
manner
hemagglutin
inhibit
assay
analyz
manner
analog
hemagglutin
assay
briefli
serial
dilut
sugar
sampl
ml
mix
equal
volum
lectin
unit
microtit
plate
incub
min
room
temperatur
ml
erythrocyt
suspens
ad
well
mix
plate
read
h
minimum
concentr
sugar
final
reaction
mixtur
complet
inhibit
eight
hemagglutin
unit
lectin
prepar
calcul
tricinesodium
dodecyl
sulphat
polyacrylamid
gel
electrophoresi
tricinesdspag
perform
accord
method
gger
von
jagow
sampl
mix
tricinesd
sampl
buffer
presenc
absenc
run
tristricin
gel
tricinesd
run
buffer
stain
coomassi
blue
appar
molecular
mass
purifi
lectin
determin
use
sephacryl
column
cm
cm
equilibr
elut
mm
pb
ph
flow
rate
mlmin
monitor
nm
molecular
mass
elut
lectin
estim
plot
log
molecular
weight
versu
distribut
coeffici
k
av
calcul
elut
volum
standard
marker
matrixassist
laser
desorptionion
timeofflight
malditof
mass
spectrum
obtain
use
voyagerrp
mass
spectromet
persept
biosystem
accord
method
woo
et
al
effect
temperatur
ph
hemagglutin
activ
determin
incub
purifi
lectin
min
differ
buffer
ph
rang
overnight
vestigi
hemagglutin
activ
determin
adjust
mixtur
ph
room
temperatur
follow
tricinesdspag
lectin
transfer
polyvinyliden
difluorid
pvdf
membran
biorad
stain
coomassi
brilliant
blue
band
correspond
lectin
excis
membran
ntermin
amino
acid
sequenc
determin
use
hewlettpackard
hp
edman
degrad
unit
hp
hplc
system
blastp
method
ncbi
manual
data
mine
use
search
homolog
sequenc
ingel
digest
cml
carri
use
mass
spectrometri
grade
trypsin
gold
promega
madison
wi
accord
manufactur
instruct
briefli
band
cml
excis
sdspage
gel
stain
coomassi
brilliant
blue
merck
cut
small
piec
destain
twice
mm
nh
hco
acetonitril
acn
min
dehydr
acn
dri
gel
preincub
ml
trypsin
solut
ngul
h
suffici
digest
buffer
mm
nh
hco
acn
ad
cover
gel
incub
mildli
shaken
overnight
h
tryptic
digest
extract
use
milliq
water
follow
doubl
extract
acn
tfa
h
time
combin
extract
dri
speedvac
concentr
thermo
scientif
sampl
subject
mass
spectrometri
analysi
mass
spectra
perform
use
qtof
mass
spectromet
micromass
manchest
uk
fit
maldi
sourc
micromass
matrixassist
laser
desorpt
ionis
timeofflight
mass
spectrometri
maldiqtof
analys
tryptic
fragment
cml
perform
describ
previous
spectra
accumul
satisfactori
sn
obtain
parent
mass
peak
rang
mz
pick
msm
analysi
peptid
mass
fingerprint
cml
msm
data
acquir
process
use
masslynx
v
softwar
micromass
convert
pkl
file
proteinlynx
softwar
water
pkl
file
analyz
use
mascot
search
engin
http
wwwmatrixsciencecom
search
paramet
defin
follow
databas
swissprot
taxonomi
homo
sapien
enzym
trypsin
allow
one
miss
cleavag
carbamidomethyl
select
fix
modif
oxid
methionin
allow
variabl
peptid
fragment
mass
toler
set
da
ms
msm
respect
use
previous
establish
procedur
vitro
antivir
activ
cml
determin
varieti
dna
rna
virus
cytotox
host
cell
line
assay
parallel
standard
drug
known
antivir
activ
cell
cultur
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
mem
nonessenti
amino
acid
kul
penicillin
gl
streptomycin
presenc
co
hela
cell
grown
medium
supplement
vv
heat
inactiv
min
fetal
bovin
serum
fb
lglutamin
kul
penicillin
gl
streptomycin
maintain
humidifi
atmospher
contain
co
air
experi
cell
plate
h
treatment
allow
adher
test
perform
accord
method
liu
et
al
hela
cell
seed
microtit
plate
cell
seed
densiti
cellwel
cultur
plate
h
incub
cell
treat
without
gener
caspas
inhibitor
zvadfmk
inhibitor
zdevdfmk
inhibitor
zietdfmk
given
concentr
h
prior
administr
lectin
mtt
assay
determin
describ
assess
effect
carbohydr
cmlinduc
cell
death
mtt
assay
determin
except
lectin
preincub
min
carbohydr
half
fulli
inhibit
hemagglutin
activ
prior
applic
test
cell
divid
three
group
place
cultur
plate
h
incub
first
group
treat
control
medium
second
group
pmoll
pm
purifi
lectin
third
group
pm
lectin
whose
hemagglutin
activ
half
fulli
inhibit
carbohydr
cellular
morpholog
observ
use
phase
contrast
microscopi
leica
wetzlar
germani
chang
nuclear
morpholog
apoptot
cell
investig
label
cell
fluoresc
select
dnaand
rnabind
dye
ao
well
examin
fluoresc
microscopi
treat
without
lectin
pm
h
cell
stain
mgml
ao
min
nuclear
morpholog
observ
fluoresc
microscopi
olympu
tokyo
ldh
activ
assess
use
standard
kinet
determin
kit
zhongsheng
ldh
kit
beij
china
ldh
activ
measur
float
dead
cell
viabl
adher
cell
float
cell
collect
cultur
medium
centrifug
g
min
ldh
content
pellet
use
index
apoptot
cell
death
ldhp
ldh
releas
cultur
supernat
extracellular
ldh
ldhe
use
index
necrot
death
ldh
present
adher
viabl
cell
intracellular
ldh
ldhi
percentag
apoptot
necrot
cell
death
calcul
follow
dna
extract
detect
dna
fragment
cellular
dna
extract
accord
method
previous
report
briefli
cell
incub
without
cml
h
wash
twice
pb
incub
digest
buffer
mmoll
trishcl
ph
mmoll
edta
kept
min
lysat
centrifug
g
min
supernat
incub
rnase
mgml
h
incub
proteinas
k
mgml
h
supernat
mix
nacl
isopropanol
overnight
follow
centrifug
g
min
dri
dna
dissolv
te
buffer
separ
agaros
gel
electrophoresi
contain
mgml
ethidium
bromid
v
min
visual
photograph
uv
light
cell
treat
pm
lectin
h
adher
float
cell
collect
western
blot
analysi
carri
describ
previous
briefli
cell
pellet
resuspend
lysi
buffer
consist
mmoll
hepe
ph
mm
sodium
orthovanada
mm
sodium
fluorid
mm
edet
acid
mm
pmsf
mgml
aprotinin
mgml
leupeptin
lyse
h
g
centrifug
min
protein
content
supernat
determin
biorad
protein
assay
biorad
laboratori
hercul
ca
usa
separ
electrophoresi
sdspolyacrylamid
gel
electrophoresi
blot
onto
nitrocellulos
membran
amersham
bioscienc
piscataway
nj
membran
soak
block
buffer
skim
milk
protein
detect
use
polyclon
antibodi
visual
use
antirabbit
antimous
igg
conjug
peroxidas
hrp
tetrahydrochlorid
dab
hrp
substrat
present
data
result
confirm
least
three
independ
experi
data
express
mean
ae
sd
statist
comparison
made
student
ttest
p
consid
statist
signific
ion
exchang
gel
filtrat
chromatograph
step
appli
purif
lectin
crude
extract
protein
load
onto
deaesepharos
column
unbound
fraction
elut
equilibr
buffer
bound
fraction
b
c
elut
linear
gradient
nacl
fig
hemagglutin
activ
test
employ
monitor
purif
procedur
show
lectin
enrich
fraction
c
activ
fraction
pool
appli
sephacryl
column
resolv
two
fraction
e
fig
fraction
e
major
hemagglutin
activ
demonstr
molecular
mass
kda
tricinesdspag
design
c
montana
lectin
cml
fig
summari
purif
provid
tabl
yield
purifi
cml
crude
protein
extract
specif
activ
increas
tricinesdspag
analysi
show
molecular
mass
purifi
lectin
approxim
kda
presenc
absenc
respect
fig
gel
filtrat
cml
sephacryl
gave
symmetr
singl
peak
molecular
weight
approxim
kda
fig
mass
spectrometri
analysi
appear
peak
correspond
mz
da
fig
result
indic
cml
homodim
consist
two
ident
subunit
da
held
togeth
disulphid
linkag
hemagglutin
activ
cml
stabl
min
decreas
sharpli
complet
abolish
incub
less
min
agglutin
markedli
affect
ph
rang
wherea
activ
observ
ph
respect
cml
agglutin
rabbit
erythrocyt
mgml
show
agglutin
toward
chook
human
blood
group
ab
b
erythrocyt
even
mgml
preliminari
carbohydr
specif
assay
show
saccharid
glycoprotein
test
yeast
mannan
rich
oligomannosidictyp
glycan
thyroglobulin
glycoprotein
inhibit
agglutin
rabbit
erythrocyt
date
shown
refin
carbohydratebind
specif
much
saccharid
differ
branch
oligomannosid
studi
detail
tabl
inhibit
complex
carbohydr
divaricatum
v
volvacea
g
lucidum
ntermin
amino
acid
sequenc
cml
dnvkysgqvkntgsa
homolog
sequenc
found
blastp
search
also
manual
data
search
compar
ntermin
amino
acid
sequenc
lectin
report
previous
suggest
cml
might
novel
lectin
show
similar
ntermin
known
lectin
cml
identifi
maldiqtof
msm
analysi
fig
peptid
mass
fingerprint
cml
obtain
maldiqtof
ms
analysi
msm
profil
peptid
fragment
mass
analyz
use
mascot
search
engin
swissprot
protein
databas
total
queri
valu
mows
score
higher
indic
homolog
data
shown
result
show
cml
match
protein
lectin
databas
search
measur
inhibitori
effect
viral
cytopathogen
effect
cpe
cell
cultur
cml
expos
differ
cell
cultur
infect
varieti
dna
rna
virus
found
cml
show
rel
low
cytotox
uninfect
control
cell
antihiv
activ
cml
examin
use
cem
cell
cultur
result
show
obviou
antihiv
activ
mgml
valu
ae
ae
respect
tabl
cml
also
exert
mark
activ
toward
influenza
subtyp
influenza
subtyp
influenza
b
mgml
valu
tabl
cml
also
possess
activ
toward
virus
viru
even
thought
activ
strong
tabl
inhibit
cell
prolifer
measur
mtt
assay
found
pm
cml
exert
potent
cytotox
effect
hela
cell
show
concentrationdepend
manner
h
incub
pm
cml
inhibit
hela
cell
prolifer
ae
ae
fig
cml
stronger
effect
cell
caus
ae
cell
growth
reduct
pm
wherea
even
pm
cml
inhibitori
ratio
cell
ae
thu
particularli
interest
investig
potent
effect
h
incub
pm
cml
suffici
inhibit
cell
growth
ic
stain
ao
cell
observ
fluoresc
microscopi
shown
fig
rna
cytoplasm
nucleolu
appear
red
dna
nucleu
green
chartreus
observ
among
cml
pm
treat
cell
dens
chartreus
nucleolu
condens
chromatin
fragment
nuclei
observ
also
reduct
nuclear
volum
nucleu
degener
discret
spheric
fragment
highli
condens
chromatin
fig
character
lectininduc
cell
death
ratio
ldh
releas
viabl
cell
float
dead
cell
cultur
medium
compar
number
apoptot
necrot
cell
h
respect
suggest
number
apoptot
cell
unregul
lower
number
necrot
cell
progress
increas
concentr
cml
especi
incub
cell
pm
cml
demonstr
major
reason
cmlinduc
cell
death
apoptosi
rather
necrocytosi
fig
distinct
biochem
hallmark
apoptosi
activ
endogen
ca
mg
depend
endonucleas
endonucleasemedi
cleavag
internucleosom
gener
oligonucleotid
fragment
bp
length
polym
characterist
ladder
band
obtain
agaros
gel
electrophoresi
dna
extract
apoptot
cell
studi
dna
ladder
band
could
observ
pm
cmltreat
group
h
wherea
presenc
cml
h
control
group
smearlik
dna
degrad
observ
shown
fig
phenomena
demonstr
cmlinduc
apoptosi
timedepend
manner
assess
effect
sugar
cmlinduc
cell
death
cml
preincub
min
buffer
contain
mana
mannotrios
mm
mana
man
mm
respect
cell
inhibitori
ratio
measur
mtt
assay
x
ae
sd
n
result
show
mana
man
slightli
effect
inhibitor
mana
tabl
activ
cytostat
properti
clemati
montana
lectin
cml
human
tlymphocyt
cem
cell
gna
galanthu
nivali
agglutinin
lra
lycori
radiat
agglutinin
sca
scilla
campanulata
agglutinin
ec
effect
concentr
concentr
requir
protect
cem
cell
cytopathogen
hiv
cc
cytotox
concentr
concentr
requir
reduc
cem
cell
viabil
mannotrios
fig
cml
preincub
mana
mannotrios
concentr
mm
abrog
almost
cml
bind
cell
inhibitori
ratio
abruptli
decreas
apoptot
phenomenon
observ
fig
furthermor
inhibitor
zietdfmk
mm
zdevdfmk
mm
pancaspas
inhibitor
zvadfmk
mm
partial
block
apoptosi
cell
fig
western
blot
analysi
carri
confirm
particip
shown
fig
cell
treat
cml
h
express
decreas
express
increas
cultur
time
suggest
activ
report
poli
adpribos
polymeras
parp
inhibitor
caspasedepend
dnase
icad
substrat
subsequ
icad
parp
express
examin
exposur
cml
icad
degrad
cleavag
parp
examin
protein
express
declin
degrad
product
increas
cultur
time
present
studi
novel
mannosebind
lectin
obviou
antivir
potent
antineoplast
activ
purifi
c
montana
buchham
stem
ranunculacea
first
time
though
nacetylgalactosaminespecif
lectin
purifi
previous
winter
aconit
e
hyemali
repres
plant
famili
ranunculacea
howev
signific
differ
caulom
although
winter
aconit
e
hyemali
c
montana
belong
famili
winter
aconit
e
hyemali
identifi
herbac
plant
c
montana
identifi
woodi
plant
cml
may
differ
larg
lectin
purifi
winter
aconit
due
remark
differ
two
plant
extraordinari
natur
c
montana
purif
cml
raw
materi
timeconsum
process
demand
larg
amount
plant
materi
even
procedur
anion
exchang
chromatographi
gel
filtrat
chromatographi
final
yield
cml
mere
approxim
mg
lectin
per
kilogram
dri
stem
materi
howev
yield
lectin
plant
seed
reportedli
rang
addit
anoth
similar
yield
report
lectin
jasmon
acid
treat
tobacco
leav
approxim
mg
lectin
per
kilogram
fresh
leav
indic
content
cml
quit
low
assay
carbohydratebind
specif
indic
cml
high
affin
complex
carbohydr
yeast
mannan
contain
oligomannosidictyp
glycan
termin
nonreduc
mannosyl
residu
mana
mannotrios
effect
inhibitor
hemagglutin
activ
lectin
nevertheless
agglutin
inhibit
dmannos
amethylmannosid
result
indic
cml
recogn
oligosaccharid
sequenc
contain
branch
oligomannosid
demonstr
lectin
possess
extend
carbohydratebind
site
accommod
highli
branch
oligomannosid
phenomenon
observ
monocot
mannosebind
lectin
h
tuberosu
constricta
lectin
mannosespecif
plant
lectin
show
antivir
activ
especi
monocot
mannosebind
lectin
antihiv
activ
p
cyrtonema
lectin
galanthu
nivali
snowdrop
agglutinin
gna
antihsv
activ
ophiopogon
japonicu
lectin
cml
also
show
mark
antivir
activ
variou
virus
cell
cultur
like
aforement
mannosebind
lectin
howev
cml
exhibit
sequenc
similar
known
lectin
especi
previous
report
mannosebind
lectin
accord
result
ntermin
homolog
search
maldiqtof
msm
analysi
databas
search
thu
cml
might
novel
mannosebind
plant
lectin
report
lectin
famili
howev
ntermin
homolog
search
blastp
method
ncbi
manual
data
mine
peptid
mass
fingerprint
analysi
remark
enough
prove
conclus
cml
complet
novel
lectin
furthermor
lectin
may
also
possess
unknown
signific
biolog
activ
explor
follow
investig
cml
futur
studi
aim
molecular
clone
sequenc
analysi
cml
base
clone
result
inform
obtain
classif
lectin
would
clearli
defin
recent
remark
antineoplast
activ
plant
lectin
driven
much
attent
cancer
studi
con
wide
studi
mannoseglucosebind
lectin
cytotox
inhibitori
numer
cancer
cell
line
report
remark
antineoplast
activ
recent
great
number
studi
report
ideal
anticanc
candid
drug
induc
apoptosi
suscept
cancer
cell
like
anticanc
drug
cml
execut
dosedepend
growthinhibitori
effect
four
typic
cancer
cell
base
upon
morpholog
observ
found
cmlinduc
cell
apoptosi
moreov
mtt
assay
also
indic
cml
activ
exert
cytotox
cell
axiomat
cancer
therapi
work
two
differ
way
induct
apoptosi
well
direct
cytox
thu
studi
mechan
cmlinduc
cell
apoptosi
perform
inspir
find
cml
abl
activ
subsequ
activ
whose
substrat
parp
icad
icad
caspas
substrat
cleav
inactiv
allow
cad
execut
characterist
fragment
dna
thu
icad
express
cell
examin
confirm
activ
role
substanti
associ
particip
caspas
inhibitor
also
seem
restrict
apoptosi
mediat
upstream
death
receptor
pathway
mitochondri
pathway
consequ
base
upon
observ
report
suggest
abovement
two
major
pathway
like
exist
apoptosi
induc
cml
investig
possibl
mechan
would
clearli
affect
outcom
lectin
includ
wide
varieti
agent
current
use
cancer
treatment
pharmaceut
applic
addit
con
also
found
mediat
apoptosi
autophagi
program
cell
death
ii
mitochondri
pathway
cancer
cell
current
studi
found
typic
caspasedepend
apoptosi
particip
three
caspas
inhibitor
western
blot
analysi
distinct
antineoplast
mechan
might
due
cmlinduc
cleav
icad
parp
express
cell
treat
pm
cml
indic
time
period
follow
western
blot
analysi
detect
icad
parp
express
bactin
use
equal
load
control
fine
differ
carbohydratebind
site
studi
indic
antitumor
activ
decreas
abruptli
phenomenon
apoptosi
almost
disappear
carbohydratebind
site
fulli
inhibit
thu
cml
bind
might
predomin
reason
spark
signific
antitumor
biolog
characterist
even
cast
crucial
impact
potenti
apoptot
mechan
recent
year
research
report
pclinduc
apoptosi
cell
comparison
antiprolif
apoptosisinduc
activ
among
pcl
ojl
lnl
cell
addit
major
lectin
famili
rip
ii
also
report
induc
apoptosi
variou
cancer
cell
sever
year
result
indic
variou
lectin
familiesinduc
apoptot
mechan
caspasedepend
pathway
would
provid
clue
elucid
antitumor
activ
mechan
lectin
studi
accordingli
interest
find
would
drive
us
princip
forc
explor
signific
correl
carbohydratebindingspecif
antineoplast
molecular
mechan
summari
purifi
cml
clemati
genu
character
signific
biolog
characterist
especi
antivir
apoptosisinduc
activ
first
time
due
accumul
evid
find
cml
exhibit
remark
antivir
apoptosisinduc
activ
would
open
new
explor
plant
lectin
potenti
candid
drug
furthermor
might
provid
promis
insight
pharmaceut
exploit
treatment
differ
human
diseas
near
futur
